Subscribe to RSS
DOI: 10.1055/a-1993-3714
Easy Route to New Fused Dihydroisoquinoline-Naphthyridinone Frameworks
This work was supported by the Russian Science Foundation (grant No. 22-13-00356).

Abstract
The reaction of 1-methyl-3,4-dihydroisoquinolines with azlactone, obtained from hippuric acid and phthalic anhydride, provided 2-(3-benzamido-4-oxo-6,7-dihydro-4H-pyrido[2,1-a]isoquinolin-2-yl)benzoic acids, which were converted into previously unknown dihydroisoquinoline-naphthyridinones by the action of hydrazine hydrate. Further reaction of the prepared naphthyridine-5,7-diones with POCl3 under various conditions led to the formation of 5-chloro-9,10-dihydro-7H-benzo[c]isoquinolino[1,2-g][1,7]naphthyridin-7-ones or 4,6-dichloro-2-(2-(2-methylprop-1-en-1-yl)phenyl)benzo[c][1,7]naphthyridines. It was also shown that the halogen atom in the C-5 position enters into a substitution reaction with primary and secondary amines.
Key words
azlactone - benzo[c][1,7]naphthyridin-4(3H)-one - naphthyridine - рyrido[2,1-a]isoquinoline - pyridone-pyridol tautomerismSupporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/a-1993-3714.
- Supporting Information
Publication History
Received: 28 October 2022
Accepted: 06 December 2022
Accepted Manuscript online:
06 December 2022
Article published online:
04 January 2023
© 2022. Thieme. All rights reserved
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Touré BB, Hall DG. Chem. Rev. 2009; 109: 4439
- 2 Valipour M. ACS Pharmacol. Transl. Sci. 2022; 5: 387
- 3 Akinboye ES, Bakare O. Open Nat. Prod. J. 2011; 4: 8
- 4 Runikhina S, Eremin D, Chusov D. Chem. Eur. J. 2021; 27: 15327
- 5 Fasano A, Bentivoglio AR. Expert Opin. Pharmacother. 2009; 10: 2883
- 6 Chrzanowska M, Grajewska A, Rozwadowska MD. Chem. Rev. 2016; 116: 12369
- 7 Bowen EG, Wardrop DJ. J. Am. Chem. Soc. 2009; 131: 6062
- 8 Takada K, Uehara T, Nakao Y, Matsunaga S, Van Soest RW. M, Fusetani N. J. Am. Chem. Soc. 2004; 126: 187
- 9 Pailee P, Prachyawarakorn V, Mahidol C, Ruchirawat S, Kittakoop P. Eur. J. Org. Chem. 2011; 3809
- 10 Itoh A, Tanahashi T, Nagakura N. J. Nat. Prod. 1995; 58: 1228
- 11 Spurr PR. Tetrahedron Lett. 1995; 36: 2745
- 12 Kanintronkul Y, Worayuthakarn R, Thasana N, Winayanuwattikun P, Pattanapanyasat K. Anticancer Res. 2011; 928: 921
- 13 Chrzanowska M, Dreas A, Rozwadowska MD. Tetrahedron: Asymmetry 2004; 15: 1113
- 14 Liu X, Zhang Y, Zhou GJ, Hou Y, Kong Q, Lu JJ, Zhang Q, Chen X. Toxicol. Appl. Pharmacol. 2020; 404: 115179
- 15 Han AR, Kim HR, Kil YS, Kang U, Jang DS, Seo EK. Chem. Nat. Compd. 2018; 54: 1020
- 16 Jahangir, Brook MA, MacLean DB, Holland HL. Can. J. Chem. 1987; 65: 2362
- 17 Nishiyama T, Hironaka M, Taketomi M, Taguchi E, Kotouge R, Shigemori Y, Hatae N, Ishikura M, Choshi T. Eur. J. Org. Chem. 2018; 673
- 18 Wang YM, Ming WZ, Liang H, Wang YJ, Zhang YH, Meng DL. Bioorg. Chem. 2020; 95: 103489
- 19 Barbosa-Filho JM, Piuvezam MR, Moura MD, Silva MS, Lima KV. B, Da-Cunha EV. L, Fechine IM, Takemura OS. Rev. Bras. Farmacogn. 2006; 16: 109
- 20 Li CL, Tan LH, Wang YF, Luo CD, Chen H-B, Lu Q, Li YC, Yang XB, Chen JN, Liu YH, Xie JH, Su ZR. Phytomedicine 2019; 52: 272
- 21 Boehringer M, Kuhn B, Mattei P, Narquizian R. Patent US7122555, 2006
- 22 Boehringer M, Kuhn B, Luebbers T, Mattei P, Narquizian R, Wessel HP. Patent US7718666, 2010
- 23 Jung M, Park M, Lee H, Kang Y.-H, Kang E, Kim S. Curr. Med. Chem. 2006; 13: 1203
- 24 Yue SJ, Liu J, Feng WW, Zhang FL, Chen JX, Xin LT, Peng C, Guan HS, Wang CY, Yan D. Front. Pharmacol. 2017; 8: 1
- 25 Hostalkova A, Marikova J, Opletal L, Korabecny J, Hulcova D, Kunes J, Novakova L, Perez DI, Jun D, Kucera T, Andrisano V, Siatka T, Cahlikova L. J. Nat. Prod. 2019; 82: 239
- 26 Ning H, Lu W, Jia Q, Wang J, Yao T, Lv S, Li Y, Wen H. Invest. New Drugs 2021; 39: 386
- 27 Zhang Y, Yao Y, Fu Y, Yuan Z, Wu X, Wang T, Hong Z, Yang Y, Wu H. J. Ethnopharmacol. 2021; 278: 114267
- 28 Guo W, Huang J, Wang N, Tan HY, Cheung F, Chen F, Feng Y. Front. Pharmacol. 2019; 10: 1185
- 29 Pashev AS, Burdzhiev NT, Stanoeva ER. Org. Prep. Proced. Int. 2016; 48: 425
- 30 Worayuthakarn R, Nealmongkol P, Ruchirawat S, Thasana N. Tetrahedron 2012; 68: 2864
- 31 Worayuthakarn R, Thasana N, Ruchirawat S. Org. Lett. 2006; 8: 5845
- 32 Shuvalov VYu, Samsonenko AL, Rozhkova YuS, Morozov VV, Shklyaev YuV, Fisyuk AS. ChemistrySelect 2021; 6: 11265
- 33 Shuvalov VuY, Rozhkova YuS, Plekhanova IV, Kostyuchenko AS, Shklyaev YuV, Fisyuk AS. Chem. Heterocycl. Compd. 2022; 58: 7
- 34 Shklyaev YuV, Yeltsov MA, Rozhkova YuS, Tolstikov AG, Dembitsky VM. Heteroat. Chem. 2004; 15: 486
- 35 Shklyaev YV, Nifontov YV. Russ. Chem. Bull. 2002; 51: 844
- 36 Moreno L, Cabedo N, Boulangé A, Párraga J, Galán A, Leleu S, Sanz M.-J, Cortes D, Franck X. Eur. J. Med. Chem. 2013; 69: 69
- 37 Kulakov IV, Palamarchuk IV, Shulgau ZT, Seilkhanov TM, Gatilov YV, Fisyuk AS. J. Mol. Struct. 2018; 1166: 262
- 38 Shatsauskas AL, Abramov AA, Chernenko SA, Kostyuchenko AS, Fisyuk AS. Synthesis 2020; 52: 227
- 39 Shatsauskas A, Shatalin Y, Shubina V, Zablodtskii Y, Chernenko S, Samsonenko A, Kostyuchenko A, Fisyuk A. Dyes Pigm. 2021; 187: 109072
- 40 Shatsauskas AL, Shatalin YV, Shubina VS, Chernenko SA, Kostyuchenko AS, Fisyuk AS. Dyes Pigm. 2022; 204: 110388
- 41 Kulakov IV, Shatsauskas AL, Matsukevich MV, Palamarchuk IV, Seilkhanov TM, Gatilov YV, Fisyuk AS. Synthesis 2017; 49: 3700
- 42 Shatsauskas AL, Mamonova TE, Stasyuk AJ, Chernenko SA, Slepukhin PA, Kostyuchenko AS, Fisyuk AS. J. Org. Chem. 2020; 85: 10072
- 43 Katritzky AR, Karelson M, Harris PA. Heterocycles 1991; 32: 329
- 44 Calabrese C, Maris A, Uriarte I, Cocinero EJ, Melandri S. Chem. Eur. J. 2017; 23: 3595
- 45 Kuo J. J. Phys. Chem. A 2021; 125: 4306
- 46 Katritzky AR, Lagowski JM. Adv. Heterocycl. Chem. 1963; 1: 339
- 47 Savchenko O. А, Musiyak VV, Goncharov DS, Bogza YuP, Shatsauskas AL, Talzi VP, Evdokimov SN, Ulyankin EB, Fisyuk AS. Chem. Heterocycl. Compd. 2020; 56: 1180
- 48 Oki M. Application of Dynamic NMR Spectroscopy to Organic Chemistry. VCH Publishers; Weinheim: 1985